Amphastar Pharmaceuticals, Inc. (AMPH) Operating margin 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) operating margin by fiscal year — reported operating income divided by reported revenue.
19.5%FY2025 · since FY2016: 6.0% → 19.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 19.5% | -8.6 pp |
| FY2024 | 28.1% | -2.5 pp |
| FY2023 | 30.6% | +9.0 pp |
| FY2022 | 21.5% | +5.6 pp |
| FY2021 | 16.0% | +12.8 pp |
| FY2020 | 3.1% | +3.1 pp |
| FY2019 | 0.0% | +2.9 pp |
| FY2018 | -2.9% | -2.4 pp |
| FY2017 | -0.5% | -6.6 pp |
| FY2016 | 6.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice